PT# | Pathology | GTV | GTV + 3 mm | Isodose volume | Excess Brain | IDL/GTV | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
PRE | POST | PRE | POST | PRE | POST | PRE | POST | PRE | POST | |||
1 | NSCLC | 14.85 | 27.67 | 35.1 | 48.79 | 52.28 | 72.19 | 24.51 | 29.08 | 3.520539 | 2.608963 | |
2 | Bladder/transitional cell | 3.36 | 3.39 | 11.45 | 11.83 | 15.86 | 18.38 | 11.99 | 14.39 | 4.720238 | 5.421829 | |
3 | NSCLC | 23.89 | 8.97 | 41 | 16.73 | 57.38 | 22.98 | 26.16 | 13.54 | 2.401842 | 2.561873 | |
4 | Lung-papillary adenocarcinoma | 0.34 | 2.33 | 1.84 | 6.81 | 2.57 | 10.41 | 1.97 | 7.34 | 7.558824 | 4.467811 | |
5 | Carcinoid | 67.88 | 6.06 | 116.62 | 17.79 | 165.83 | 27.53 | 93.5 | 20.52 | 2.442988 | 4.542904 | |
6 | NSCLC | 37.32 | 27.81 | 63.61 | 53.71 | 101.23 | 90.5 | 61.77 | 62.11 | 2.712487 | 3.254225 | |
7 | melanoma | 0.06 | 5.85 | 0.79 | 18.16 | 1.09 | 31.05 | 0.97 | 18.22 | 18.16667 | 5.307692 | |
8 | Lung-papillary adenocarcinoma | 2.8 | 9.57 | 7.4 | 21.87 | 10.93 | 27.53 | 6.73 | 13.22 | 3.903571 | 2.876698 | |
9 | NSCLC | 1.8 | 5.87 | 5.68 | 14.34 | 8.6 | 21.02 | 6.78 | 12.39 | 4.777778 | 3.58092 | |
10 | Lung adenocarcinoma | 0.33 | 1.55 | 1.82 | 7.05 | 2.8 | 9.92 | 2.44 | 7.07 | 8.484848 | 6.4 | |
10 | Lung adenocarcinoma | 17.39 | 4.8 | 32.3 | 17.04 | 47.78 | 24.22 | 23.49 | 14.36 | 2.747556 | 5.045833 | |
11 | Lung squamous cell | 11.38 | 22.18 | 22.78 | 45.05 | 35.57 | 82.05 | 17.41 | 33.59 | 3.125659 | 3.699279 | |
12 | Lung adenocarcinoma | 6.09 | 9.64 | 14.11 | 20.74 | 22.73 | 32.16 | 13.02 | 15.6 | 3.732348 | 3.3361 | |
min | 0.06 | 1.55 | 0.79 | 6.81 | 1.09 | 9.92 | 0.97 | 7.07 | ||||
max | 67.88 | 27.81 | 116.62 | 53.71 | 165.83 | 90.5 | 93.5 | 62.11 | ||||
average | 14.42231 | 10.43769 | 27.26923 | 23.07 | 40.35769 | 36.14923 | 22.36462 | 20.11 |